B
BiXi Li
Publications - 2
Citations - 773
BiXi Li is an academic researcher. The author has contributed to research in topics: Procalcitonin & Risk assessment. The author has an hindex of 1, co-authored 2 publications receiving 421 citations.
Papers
More filters
Journal ArticleDOI
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
TL;DR: Investigation of the ability of interleukin-6, C-reactive protein (CRP), and procalcitonin (PCT) to predict mild and severe cases of CO VID-19 showed that IL-6 and CRP could be used as independent factors to predict the severity of COVID-19.
Journal ArticleDOI
Pneumonia scoring systems for severe COVID-19: which one is better.
Cheng Pengfei,Hao Wu,Jun-zhe Yang,Xiaoyang Song,MengDa Xu,BiXi Li,JunJun Zhang,Ming-Zhe Qin,Cheng Zhou,Xiang Zhou +9 more
TL;DR: In this paper, the authors investigated the predictive significance of different pneumonia scoring systems in clinical severity and mortality risk of patients with severe novel coronavirus pneumonia and found that the APACHE II score showed the largest area under ROC curve in both noninvasive and invasive respiratory support treatment assessments.